FDA Approved: * October 3, 2022
Pharm Company: * ZYDUS PHARMS USA
Category: Anticonvulsant

Brivaracetam, sold under the brand names Briviact and Brivajoy among others, a chemical analog of levetiracetam, is a racetam derivative with anticonvulsant (antiepileptic) properties.[2][3] It is marketed by the pharmaceutical company UCB.[4][5] In India it is co-promoted and distributed by Dr. Reddy's Laboratories.[not verified in body] Contents 1 Medical uses 2 Adverse effects 3 Interactions 4 Pharmacology 4... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Related Brands

Drugs with the same active ingredients